Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TDG | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | HNRNPM | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
mRNA | SMIM8 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
mRNA | CTSA | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | NAA16 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | HNRNPC | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |